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Extracranial internal carotid artery stenosis ≥ 
50% causes up to 8% of all ischemic strokes1. According 
to guidelines from the American Heart Association/
American Stroke Association2, patients with stroke and 
absent or mild disability should be submitted to carotid 
artery endarterectomy (CAE) or carotid artery stenting 
(CAS). CAS is considered an alternative to CAE for 
symptomatic patients when the rate of periprocedural 
stroke or death is <6% (Recommendation Class IIa, Level 
B). Most of the data about risks of CAS has been collected 
in developed countries3-9. There is limited information 
about rates of complications in developing countries10, 11.
The primary aim of this study was to assess 
rates of periprocedural major complications (stroke, 
myocardial infarction or death) of ICA-CAS in patients 
with symptomatic carotid stenosis at a reference academic 
hospital in São Paulo, Brazil. The secondary aims were 
to evaluate other major and minor complications of this 
procedure. 
In this single-center retrospective study, we 
evaluated medical records of consecutive patients treated 
for symptomatic carotid stenosis at Hospital das Clínicas 
/ Sao Paulo University in Brazil between April 2011 and 
March 2016. Patients aged 18 years old or more who 
underwent CAS according to the institutional protocol, 
were admitted to the Neurology Ward and followed-up by 
neurologists until discharge, were included.
We analyzed charts of 73 patients and included 
65 in the study. The following information was retrieved 
from medical records: age, gender, ethnicity, comorbities 
(hypertension, diabetes, cardiopathy, coagulopathy, 
smoking, prior stroke), interval between the onset 
symptoms and the procedure, use of antiplatelet or 
anticoagulant drugs, type of cerebrovascular event (stroke 
or transient ischemic attack), blood creatinine levels and 
National Institutes of Health Stroke Scale (NIHSS) scores.
The primary outcome was the frequency of any 
stroke, myocardial infarction (MI) or death during the 
periprocedural period (until discharge from the hospital). 
The secondary outcomes were classified in major or minor 
complications based on guidelines of the European Society 
of Cardiology12. Major complications were: intracranial 
hemorrhage, hyperperfusion syndrome, carotid artery 
perforation, acute stent thrombosis and complications at 
the site of vascular puncture. Minor complications were 
transient ischemic attacks, hypotension, vasospasm, 
bradycardia and ICA dissection. In addition, we also 
assessed the secondary outcome of relevant worsening in 
renal function (increase in creatinine blood levels of at 
least 1.5 baseline levels) 13 as a minor complication.
The main finding in the study was a rate of 
periprocedural stroke, MI or death of 4.6% (3/65). There 
were two ischemic ipsilateral recurrent strokes (3.6%). 
One patient (1.5%) had a haemorrhagic stroke and died. 
There were no myocardial infarctions. The rate of minor 
complications was 21.5% (14/65) and there were no 
permanent clinical, physical or neurological impairments.
Taken together, our results show a rate of 
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periprocedural complications due to CAS below the 
maximum recommended rate of 6% for revascularization 
procedures. Thus, CAS was safe when performed as a 
revascularization strategy in clinical practice at a high-
volume reference Brazilian center.
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